Aandeel CBPI CHINA BOTANIC PHARMACEUTICAL INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen China Botanic Pharmaceutical Inc. Other OTC

Aandelen

CBPI

US16890Y1047

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2023
Fuss Brands Corp. Announces Resignation of Issamar Ginzberg as Chief Executive Officer
Fuss Brands Corp. Announces Board Changes
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Fuss Brands Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023
FUSS BRANDS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS (form 10-K)
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2022
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Receives Purchase Order from Roomwagon, LLC
Fuss Brands Corp. Auditor Raises 'Going Concern' Doubt
Fuss Brands Corp. announced that it has received $0.078 million in funding
FUSS BRANDS CORP. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)
FUSS BRANDS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
FUSS BRANDS CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers FBDS
  4. Koers CBPI
  5. Nieuws China Botanic Pharmaceutical Inc.
  6. Andere talen